Monday, August 01, 2022 11:50:28 AM
Speculation about management motives is quite meaningless (esp. on anonymous boards).
This company is not at point zero in its development. They have accumulated vast amounts of knowledge about applying the technology to a variety of medical problems, and now they're moving toward the obvious target of food manufacture. The basic principles are the same, the differences are obvious (scale, purity, regulatory process). PLUR is well established to capitalize on its accumulated experience.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM